See what recent examples reveal

The Inside Analyst selects stocks where fundamentals and value drift apart. Top stories are published on Substack.

Favicon The Inside Analyst showing dark blue background and light blue small squares that are connected.

Uber Finally Became a Cash Machine That Looks Deceptively Cheap – Opportunity or Trap?

A Financial X-Ray on Uber reveals a business that has fundamentally improved, but one where valuation metrics paint a more nuanced picture. For years, Uber was the poster child for growth at all costs. Revenue expanded rapidly, but profits remained elusive. The company burned billions of dollars in cash, relied heavily on external funding and faced constant questions about whether its business model could ever generate sustainable returns. That story has changed. Today, Uber is consistently profitable, generates billions in free cash flow and has strengthened its balance sheet. Yet despite this remarkable transformation, the stock continues to trade below its estimated fair value.At first glance, the conclusion seems obvious.Uber looks cheap.Let’s focus on what the Financial X-Ray – a platform that covers 800+ stocks and helps you see strengths and pain points in seconds –reveals.What changed beneath the surfaceThe financial transformation over the past few years has been remarkable. The biggest change isn’t that the company generates more revenue – it’s that the business has fundamentally changed how it earns money.Revenue has grown from $13 billion in 2019 to more than $52 billion in 2025, but revenue growth alone doesn’t create shareholder value. Many technology companies can grow quickly by spending aggressively. The important question is whether that growth eventually translates into profits and cash generation. This is where Uber’s transformation becomes evident. EBITDA has improved from a $7.4 billion operating loss to almost $7 billion of positive operating earnings. This tells us the business is no longer relying on scale alone. As Uber has expanded, each additional ride and delivery has become increasingly profitable, demonstrating meaningful operating leverage (increased unit profitability). The strongest signal, however, comes from cash generation.Free cash flow has increased from negative $4.6 billion to almost $9.6 billion. Cash flow is ultimately what allows a company to repay debt, invest in future growth, acquire competitors or return capital to shareholders. A business that consistently generates cash has far more strategic flexibility than one that depends on external financing. The balance sheet tells a similar story.Net debt (total debt minus cash) has fallen steadily while return on invested capital (ROIC - that measure the profit per dollar invested) has turned positive after years of negative returns. Together, these metrics suggest that Uber is not only becoming financially stronger, but is also generating better returns from the capital already invested in the business. That is an important sign that growth is becoming more efficient rather than simply larger. Taken together, the financials show a company entering a new phase.

AUG 3 · THE INSIDE ANALYST

Inside the Portfolio #4 What Prevents Your Portfolio From Outperforming the S&P 500?

The Financial X-Ray analyses your holdings together, highlighting concentration, industry and geopolitical risks that aren’t obvious when looking at individual companies. If you’ve been reading Inside the Portfolio or my Monday evening stock analysis articles, you’ve probably noticed one recurring theme.I rarely analyse financial metrics in isolation. Strong margins don’t matter much if cash flow is deteriorating. High growth is less impressive if debt keeps rising. A cheap valuation isn’t attractive if the business is weakening etc. Professional investors assess businesses as a whole and the same principle applies to portfolios. Owning exceptional businesses doesn’t automatically create an exceptional portfolio. So how can you be confident that you own high quality stocks and that these quality stocks form a strong portfolio? That’s exactly what I built the Financial X-Ray Analysis Tool for. A paid subscriber recently gave me permission to share the analysis that the Financial X-Ray performed on his portfolio. The purpose is to share common pitfalls that most investors are not aware of. These pitfalls prevent the portfolio from beating the S&P 500.

JUL 31 · THE INSIDE ANALYST

Inside the Portfolio #5 This Quality Stock Will Beat the Market. Just Wait for One More Thing.

The Financial X-Ray doesn’t just identify exceptional companies. It tells me when to wait.

AUG 6 · THE INSIDE ANALYST

Pick a stock and see structural strenghts and pain points

Financial X-Ray

Most popular

ASML Is the AI Bottleneck – The Question Is How Much Is Already Priced In?

Combining long-term fundamental investing with the Financial X-Ray framework to separate market expectations from business reality. ASML sits at the center of the global semiconductor industry, dominates a critical technology stack and continues to deliver strong growth, profitability and cash generation. Every advanced semiconductor – whether used in AI servers, smartphones, autonomous vehicles or data centres – must first be manufactured using lithography equipment, making ASML a critical supplier to the global chip industry. ASML makes money in two ways: Net Bookings of hardware sales (i.e. lithography machines), and Installed Base Management (regular updates and software services). The former makes up about 2/3 of revenues, while the latter represents about 1/3 of total revenues. This is a crucial distinction because the former represents lumpy machinery sales, while the latter is a smooth, recurring revenue stream that turns over come rain or shine.

JUL 3 · THE INSIDE ANALYST

NVIDIA's Investment Case Rests on One Hidden Assumption.

The Financial X-Ray highlights an extraordinary business whose future still depends on maintaining exceptional conditions. NVIDIA’s financial transformation has been extraordinary.Revenue increased from just $11 billion in 2020 to more than $215 billion in 2026. EBITDA margins expanded from 31% to almost 67%, while free cash flow exceeded $95 billion. Return on invested capital climbed above 55% and the company now operates with virtually no net debt. Few companies have ever combined this level of growth, profitability and capital efficiency. Yet one characteristic has become even more pronounced. Nearly 90% of NVIDIA’s revenue now comes from its Data Center business. The company has become financially stronger than ever. It has also become more dependent on one extraordinary source of demand.

JUN 29 · THE INSIDE ANALYST

Pfizer Looks Cheap And Safe. So Why Is It Still a Poor Investment?

For many investors, Pfizer appears to be exactly the kind of stock value investing is built on.It is one of the world’s largest pharmaceutical companies, owns a portfolio of globally recognized medicines and pays an attractive dividend. After the extraordinary COVID boom, the share price has fallen sharply while valuation multiples have compressed.Many investors see opportunity. Using a different lens – the Financial X-Ray – to evaluate several financials metrics together and not in isolation, reveals an important tension beneath the surface. Recall that low valuation only reflects an investment opportunity if the current price is based on temporary pessimism instead of fundamental deterioration.Let’s dive into it. During the pandemic, Pfizer became one of the most profitable pharmaceutical companies in the world. Revenue almost doubled from $41 billion to more than $100 billion, while EBITDA margins exceeded 40%. Those numbers were extraordinary – but they were also temporary. Once COVID-related demand faded, the business changed dramatically. Revenue fell back to roughly $63 billion, EBITDA margins almost halved and free cash flow became one of the most volatile metrics in the entire healthcare sector.At the same time, net debt nearly doubled following the Seagen acquisition while returns on invested capital remained well below their pandemic highs. For context, banks usually consider a constant Net debt / EBITDA ratio below 2x as solid. Pfizer has often exceeded these level peaking at 7.1x in 2023. When debt levels rise relative to the operating performance, financial flexibility decreases which may impact future growth, investments and distribution of capital to shareholders.To understand why this matters, investors need context. Revenue growth tells us whether a business continues expanding. Margins show how much profit the company earns from every dollar of sales. Free cash flow measures the cash management can actually reinvest, repay debt with or distribute to shareholders. Return on invested capital tells us how efficiently every dollar invested in the business creates future profits. High-quality businesses usually display these metrics at a high levels, consistently over many years. Pfizer does not. Instead, each of the company’s key financial drivers has swung dramatically within only a few years. Take a closer look at the financials in the table again and try to anticipate the next year. And here is the part equity analysts don’t like. Pfizer makes forecasting considerably more difficult.

JUL 27 · THE INSIDE ANALYST

Inside the Portfolio #3 Boring Stocks Up 450% And the Moment They Become Investable

The Financial X-Ray doesn’t tell you to buy the cheapest stocks. It waits until exceptional businesses have earned the right to become long-term investments. Every month, the Financial X-Ray evaluates more than 800 publicly listed companies through the same systematic process. Only a small fraction qualify for the Financial X-Ray Selection – the portfolio that has consistently outperformed the MSCI World since inception by focusing on business quality, financial strength, management execution, growth and valuation rather than headlines or market sentiment. Most investors assume successful investing is about buying companies before everyone else discovers them. I don’t think that’s true. When the Financial X-Ray was built, the idea was never to identify the next 30-bagger or predict the next market trend - not because I wouldn’t love to know it – simply because I can’t do it with confidence. Instead, I focused on a much simpler question: Has this business demonstrated enough financial quality to deserve a place in a concentrated long-term portfolio? That distinction matters.Buying too early often means investing in hope. Buying too late means paying for perfection. The Financial X-Ray attempts to sit somewhere in the middle – waiting patiently until the financial evidence becomes compelling while the valuation still provides attractive long-term upside. This week I’d like to show you exactly how that decision process works.Not by discussing the algorithm itself.But by walking through one company that eventually qualified for the Financial X-Ray Selection. Every company entering the Financial X-Ray Selection must satisfy a demanding set of criteria. Financial health must be robust enough to withstand difficult markets. Management must demonstrate disciplined capital allocation. Growth prospects cannot be weak. Valuation must still provide sufficient upside despite the company’s quality. Most importantly, the overall assessment must be Strong. No single ratio determines the outcome. A low P/E ratio alone doesn’t qualify a company. High revenue growth alone doesn’t qualify a company. Even excellent profitability isn’t enough if investors have already priced in years of perfection. The Financial X-Ray weighs all of these characteristics together. That is why relatively few businesses make the final portfolio. The stock I’d like to discuss is up 450% since June 2023 and has delivered well on all criteria.

JUL 24 · THE INSIDE ANALYST

Snowflake Generates Cash. So Why Is It Still a Speculative Bet?

Free cash flow can overstate business quality when cash generation depends on shareholder dilution rather than operating profits. Snowflake has become one of Wall Street's favorite AI infrastructure companies. Its cloud-native Data Cloud enables enterprises to store, organize and analyze massive amounts of data across different cloud providers – making it a critical layer for modern analytics and artificial intelligence applications.Investors have rewarded that position with a premium valuation, betting that rapid adoption will eventually translate into exceptional profitability. Let’s dive into it and see how snowflake performs under the Financial X-Ray - a structured lens to evaluate quality in seconds. What changed beneath the surface. On almost every operating metric, Snowflake has delivered exceptional growth.Revenue increased from $265 million to nearly $4.7 billion in just six years – equivalent to an annual growth rate of almost 60%. For context, most mature software companies grow between 10% and 20% annually, making Snowflake’s expansion extraordinary.Snowflake’s financial profile reveals a business where revenue continues to grow rapidly, but profitability has yet to follow. Positive free cash flow is largely supported by stock-based compensation, while returns on invested capital remain negative. Viewed together, these metrics highlight a Cash Conversion Illusion. Free cash flow has also improved dramatically, rising from negative $206 million to almost $1 billion. At first glance, this suggests the business has become highly cash generative. But the income statement tells a different story.Despite almost $5 billion in annual revenue, Snowflake still reports negative EBITDA, negative net income, and negative returns on invested capital. A mature software business would normally convert this level of revenue into attractive operating margins and double-digit returns on capital. Snowflake has not yet reached that point.This creates the central tension.The cash flow statement appears exceptionally strong. The underlying economics remain considerably weaker. This is not an obvious financial pattern, it is an illusion of cash conversion.

JUL 20 · THE INSIDE ANALYST

Inside the Portfolio #2 Two Businesses I’d Still Buy Today

The Financial X-Ray isn’t designed to predict the future. It’s designed to identify the rare moments when exceptional businesses become reasonably priced. Every month, the Financial X-Ray evaluates more than 800 listed businesses using the same systematic framework. Only a small fraction qualify for the Financial X-Ray Selection – the portfolio that has outperformed the MSCI World since its inception, not because it chases the latest winners, but because it patiently waits for quality, financial strength and valuation to align.X-Ray selected stocks vs the MSCI world index since inception. Past performance does not guarantee future results.The philosophy of the Financial X-Ray selection is simple: Strong businesses outperform when bought at the right price. 3 years is not 20 years and past performance does not guarantee future returns but the chart above shows that this framework deserves attention.Today, the Selection consists of a concentrated group of 38 businesses that continue to clear a demanding set of financial hurdles. Portfolio turnover remains intentionally low. Great businesses rarely change overnight, and neither should a disciplined investment process.That naturally raises an interesting question.If I had fresh capital to deploy today, would I still buy the companies already sitting in the portfolio?The answer isn’t automatically yes.Some businesses remain exceptional but have become too expensive. Others continue to execute well, yet no longer offer an attractive balance between quality and price. Occasionally, however, the framework identifies companies where the market’s expectations appear to have drifted too far from business reality.This month, two companies stood out.They operate in completely different industries, face very different risks and serve entirely different customers. Yet both currently earn a place in the Financial X-Ray Selection for the same underlying reason.Behind the paywall, I’ll explain why they still deserve fresh capital today – and what they reveal about how the Financial X-Ray separates great businesses from great investments.

JUL 16 · THE INSIDE ANALYST

Eli Lilly Is Revolutionising Medicine – The Market May Already Expect Too Much

The Financial X-Ray reveals a dangerous mix of accelerating growth, rising leverage and collapsing cash generation.

JUL 13 · THE INSIDE ANALYST

Inside the Portfolio #1 Stocks That Set the Foundation

These stocks contribute to the portfolio's balance and outperformance. The Financial X-Ray identifies businesses whose economics remain remarkably difficult to break. Since launching the Financial X-Ray Selection Portfolio in June 2023, one question has appeared more often than almost any other.Which companies form the basis of the portfolio and survive the rigorous quality assessments year after year? The Financial X-Ray Selection has outperformed the MSCI World since inception while maintaining a focused portfolio of 38 holdings.I don’t see that as proof that the framework is infallible, markets have a habit of humbling anyone who thinks they have found certainty.Instead, I see it as evidence that applying the same disciplined process to every business, month after month, can produce strong long-term outcomes. The conviction is simple: I don’t focus on intense trading or on chasing hype. Instead, the approach is to buy quality stocks at decent prices - or put differently, buy stocks with an X-Ray Score of “strong”.

JUL 9 · THE INSIDE ANALYST

Investing Doesn’t Have To Be Complicated

How a simple framework for buying financially strong businesses has outperformed the market since June 2023. Most investors believe better returns require more complexity. My experience suggests the opposite. I didn't start my career in finance because I wanted to predict stock prices. I wanted to understand how businesses create value, why some companies compound for decades while others slowly deteriorate, and whether those differences could be recognised before they became obvious to everyone else. Working as an equity analyst, I realised investors don't need more metrics. They need analysed conclusions they can base decisions on. And we must be able to understand how these conclusions were formed. If a company gets a “balanced” score on financial health, we must understand that this message doesn’t mean “nothing is happening”. It means that certain forces offset each other. Revenue may grow while debt explodes, strong cash generation may come with declining capital efficiency or improving margins do not convert into cashflow. As private investors we are left alone with isolated ratios, headlines and opinions. That gap is what eventually led me to build the Financial X-Ray. So instead of searching for the next winner and following headlines, reacting to earnings releases, comparing valuation multiples and constantly asking whether now is the right time to buy I’ve realised that investing is often made far more complicated than it needs to be. My simple conviction is that financially strong businesses outperform the market when bought at a sensible valuation level.Meaning: The businesses that create long-term wealth tend to share remarkably similar characteristics.

JUL 6 · THE INSIDE ANALYST

The Market Rewards Excitement. It Often Underestimates Discipline.

Three companies proving that great investments don’t always begin with a great story. Artificial intelligence. Weight-loss drugs. Quantum computing. These are the stories dominating financial headlines today. Investors naturally gravitate towards businesses with exciting narratives, rapid growth and seemingly unlimited opportunities. The result is often the same: expectations rise faster than the underlying business. Meanwhile, another group of companies quietly disappears from the conversation. They operate in mature industries. Growth is modest. Few investors discuss them on social media. Yet they consistently generate cash, strengthen their balance sheets and return capital to shareholders year after year. The Financial X-Ray identified three companies that fit this profile remarkably well. They offer something less exciting but potentially far more valuable. Financial discipline.

JUL 2 · THE INSIDE ANALYST

Everybody Loves These Stocks. That's The Problem.

An X-Ray selection of exceptional businesses where the quality is obvious – but the upside may be harder to find. Most investment mistakes come from buying weak businesses.Some come from paying too much for strong ones.The second mistake is far more difficult to spot.When a company consistently grows, generates enormous cash flows and dominates its industry, investors naturally become willing to pay a premium. Over time, that premium can become so large that future returns depend less on business performance and more on whether expectations can continue rising.With the Financial X-Ray methodology these businesses are easy to identify.All generate elite returns on capital. All possess strong balance sheets.All continue producing healthy growth and attractive margins.Yet all face the same challenge:The market already knows it.These stocks are incredibly strong and belong on your watchlist.

JUN 25 · THE INSIDE ANALYST

Oracle Looks Like an AI Winner – But the Cost of Winning Is Exploding

The Financial X-Ray reveals a dangerous mix of accelerating growth, rising leverage and collapsing cash generation.

JUN 22 · THE INSIDE ANALYST

Looking for Value in Large Caps? Look Closer.

Three companies with attractive upside – but each comes with a catch investors cannot afford to ignore. The market loves certainty.A strong balance sheet, recurring cash flow, dominant market positions, and years of successful execution usually earn a company a premium valuation.Yet investing becomes more interesting when a business has many of these qualities while still carrying a meaningful uncertainty that divides investors.That uncertainty can take many forms. It might be dependence on a single growth engine. It might be exposure to economic cycles. Or it might be a business model that appears stronger than the market believes, but still faces questions that cannot be dismissed.In this week’s Financial X-Ray article, we examine three companies that combine attractive upside potential with genuine risks. None of them are broken businesses. In fact, all three possess qualities that many investors actively seek: strong cash generation, established competitive positions, and proven management teams.The question is whether the market is overestimating the risks – or underestimating them.Using the Financial X-Ray framework, we break down the strengths, weaknesses, valuation signals, and long-term outlook for each company to determine whether today’s uncertainty represents an opportunity or a warning.

JUN 18 · THE INSIDE ANALYST

CrowdStrike has a Strong Balance Sheet – Is It a 10-bagger or a Hidden Trap?

Investors see a cybersecurity leader with a fortress balance sheet, strong cash generation and a dominant market position. The Financial X-Ray looks beneath the surface flags common misconception. CrowdStrike continues to grow rapidly. Revenue has increased from less than $500 million to nearly $5 billion in just six years.Yet the direction of the underlying economics has become less impressive.Revenue growth has slowed from above 80% to around 20%, while EBITDA margins that show the operating resilience and scaling power of the business have deteriorated from nearly 10% to below 4%.Return on invested capital and return on equity both measure how effectively CrowdStrike uses the capital within the company. Both metrics moved back into negative territory.Free cash flow remains strong, but profitability has weakened and operating returns have failed to improve.At the same time, the balance sheet has become even stronger. Net cash continues to grow, debt is negligible and the company maintains significant financial flexibility.This creates an unusual tension: the balance sheet signals strength while operating quality is deteriorating.This situation reflects a recurring financial dynamic: Balance Sheet Mirage.

JUN 15 · THE INSIDE ANALYST

Boring Stocks Rarely Make Headlines. They Often Make Money.

Three companies with strong financial foundations, attractive valuations and surprisingly little investor enthusiasm – quality at an attractive price.

JUN 11 · THE INSIDE ANALYST

Micron Finally Works – And That’s Exactly the Risk

Micron Technology, Inc. now looks like one of the strongest beneficiaries of the AI boom. But this is not the first time Micron has looked exceptional – and that is exactly the point.

JUN 8 · THE INSIDE ANALYST

Microsoft Is an AI Winner – But Why Is Upside Limited?

Growth is solid, margins are expanding, and AI is opening a new chapter of opportunity. But beneath that strength, the financial structure of the business is beginning to shift. Microsoft’s operating performance continues to improve. Revenue growth remains strong at around 15%, supported by cloud and AI demand, while margins have expanded to very high levels.Profitability and net income continue to rise steadily.But one signal has moved sharply: capital intensity.Capex has increased significantly and has stayed volatile, reaching levels above 25% of revenue as Microsoft invests heavily in AI infrastructure and data centers.This has led to more volatile free cash flow (Recall: free cash flow is operating cash flow less money spent by the company. This metric measures the amount of money left inside the business that is available to shareholders)In addition, we observe a gradual decline in ROIC from mid-teens to around 12%. (Recall: ROIC measure the profit per dollar invested. To generate value, this number must sit above ~10%)The result is a clear shift: strong operating performance alongside rising capital requirements and slightly lower efficiency. This reflects an early-stage Capex Shock – but in a high-quality business.

JUN 1 · THE INSIDE ANALYST

The Market Loves the Story – But the Numbers Are Fragile Beneath the Surface

AI and cybersecurity optimism pushed these stocks toward perfection-level valuations, even as margin swings, cyclicality and execution risk quietly remain beneath the surface. Markets rarely become expensive by accident.Usually, a strong narrative sits underneath the valuation.Today, I’d like to focus on : AI infrastructure, cybersecurity and digital transformation.Investors are rewarding companies tied to these themes with enormous valuations – often assuming growth, margins and execution will remain exceptional for years to come.Sometimes that optimism is justified. But sometimes fragility shows up in different forms:margins that swing more than expectedcash flow that is less stable than the stock chart suggestsconcentration risks hidden behind growthcyclicality that disappears during bull markets until it suddenly returnsThe following companies are not weak businesses.In fact, all operate in attractive markets with real long-term demand drivers.But their current valuations increasingly assume that execution remains close to perfect.And that is where risk begins to matter.

MAY 28 · THE INSIDE ANALYST

Duolingo Is Getting Stronger – So Is the Stock Finally Recovering?

Revenue is expanding, profitability is improving, and the business is becoming structurally stronger. Yet the stock tells a different story, and that contrast reveals an important shift. Duolingo’s operating engine has strengthened significantly. Revenue continues to grow at nearly 40%, supported by strong user engagement and monetization – even throughout Q1 2026.At the same time, profitability has improved sharply. EBITDA margins turned positive and expanded, while net income and free cash flow increased meaningfully.Capital efficiency is also improving. ROIC, which measure the outcome for every $ invested, moved from negative territory to above 10%, indicating the business is beginning to generate returns above its cost of capital.The balance sheet remains a major strength, with a strong cash position and no meaningful financial risk.The key shift is not deterioration – it is normalization. Growth remains strong, but it is slowing from earlier extreme levels.This situation reflects a recurring financial dynamic: The Growth Normalization Paradox.

MAY 26 · THE INSIDE ANALYST

The Market Gave Up on These Stocks – The Numbers Didn't

Weak growth stories often hide what investors stop looking for: resilient cash flow, durable business segments and valuations already pricing in decline. Most investors stop digging once the narrative turns negative.Growth slows.

The stock stalls.

The market moves on.That usually creates a simple conclusion: the business is no longer interesting.But financial statements rarely deteriorate all at once.More often, weakness in one segment starts dominating perception while other parts of the business continue compounding quietly beneath the surface.When I screened the Financial X-Ray for companies trading at compressed valuations despite resilient financial foundations, several names stood out.All face narratives the market currently dislikes.And all may be far more structurally durable than investors assume.That disconnect is where things get interesting.

MAY 21 · THE INSIDE ANALYST

Nebius Is Riding AI Demand – But Its Position May Be More Replaceable Than It Looks

Major agreements with Microsoft and Meta have fueled a powerful growth narrative around AI infrastructure demand. But strong demand alone does not guarantee a durable business. Nebius is growing at an extraordinary pace. Revenue surged as demand for external AI compute capacity accelerated. The company recently signed major infrastructure agreements with Microsoft Corporation and Meta Platforms, Inc., which helped fuel the stock’s rally. These deals highlight why Nebius is growing so quickly: hyperscalers need AI compute capacity immediately. GPU shortages, power constraints and long construction timelines make it difficult for large technology companies to build enough infrastructure fast enough.But the economics remain extremely demanding. Free cash flow turned sharply negative, capex exploded to several multiples of revenue, and returns on capital remain deeply negative.This creates a clear tension: demand is real – but the underlying economics remain unproven.

MAY 18 · THE INSIDE ANALYST

When Great Businesses Become Average Investments

Most investors think buying a great company automatically leads to great returns. That logic breaks more often than people realize. The market usually recognizes exceptional businesses quickly and once that happens, future returns become increasingly dependent on valuation discipline rather than operational performance.The Financial X-Ray – a comprehensive equity research methodology – recently flagged several companies with exactly this setup:exceptional financial strengthstrong competitive positioning & moatdurable growth enginesbut only medium upsideThese aren’t weak businesses. They may simply be priced too efficiently.Three companies stood out:

MAY 15 · THE INSIDE ANALYST

AMD Is on the Rise – Valuation Prices an Elite Business Before the Economics Can Follow

Growth is accelerating and profits are improving. But the market is valuing AMD as if it has already reached NVIDIA’s economics and the financials suggest it is not there yet. AMD’s operating momentum has clearly improved. Revenue growth re-accelerated to more than 30% in 2025 as AI and data center demand strengthened. Profitability also recovered, with EBITDA, net income and free cash flow all moving sharply higher. The balance sheet remains a major strength. AMD continues to operate with net cash and limited financial risk.But two signals continue to lag: capital efficiency and stability. Firstly, ROIC – which measures the profit per dollar invested in the business – remains below 10%, far below what investors typically expect from companies priced at premium valuations. Secondly, returns remain inconsistent. A premium business requires stability and resilience. This creates a clear tension: growth is accelerating faster than economic quality. This is not a structural distortion – it is an expectations gap.

MAY 11 · THE INSIDE ANALYST

The Market May Be Wrong on These 3 Stocks – But Not for the Reasons Investors Think

These three companies screen as attractive on valuation and financial strength but each carries a weakness the market is actively pricing in. Cheap stocks are often cheap for a reason. But sometimes the market overcorrects, pricing in real risks while overlooking the durability of the underlying business. This week’s Financial X-Ray screens for companies with: High upside, Strong financials health, Strong valuation support, Real operational risks that investors cannot ignore. They all look attractive on paper. But the opportunity only makes sense if the underlying weakness proves temporary.

MAY 7 · THE INSIDE ANALYST

Cognizant Is Undervalued – But Growth Has Yet to Follow

Revenue is steady, margins hold, and the balance sheet is strong. But when the financial signals are read together, one question stands out: where is the growth?
Cognizant’s revenue base has remained stable over time, reflecting diversified demand across its service lines.Margins and returns have also held near sector averages, with only modest improvement in recent periods. But growth momentum remains weak. Revenue expansion has been slow and inconsistent despite a favorable sector backdrop driven by digital transformation and AI adoption. Cash generation adds another layer. Free cash flow is meaningful overall, but it has been volatile, with sharp swings across recent periods. The result is a clear tension: operational stability without meaningful acceleration. This situation reflects a recurring financial dynamic: Stability Overconfidence

MAY 4 · THE INSIDE ANALYST

These Large Companies Are Cheap – and the Signals Support Them

Not every cheap stock is an opportunity. The difference lies in whether valuation is supported by the underlying signals – financial health, growth, and operating quality. Normally, I highlight tension between the price of a stock and the underlying fundamentals. Today, I am going to present three companies where I ran a financial X-Ray analysis and where I see strong support at attractive valuation levels. Visa stands out because nearly all core signals align:solid growth over the past 7 year only interrupted by the pandemic in 2020strong and consistent margins above 50% - most good companies hover around 15%high returns as measured by ROIC beyond 20% (the profit per dollar invested). A value beyond 15% is excellent.Capital allocation is disciplined with accurate buyback timing, limited dilution and disciplined M&A activity making it a well managed company. What makes it compelling is not just growth, but the consistency and scalability of the model. This is a business where profitability (margins), efficiency (ROIC) and expansion (growth at scale) reinforce each other rather than trade off. The conclusion here is simple: cheap with strong underlying support.The company trades at 3.5% FCF yield and 30x PE. For a business of that quality, it is solid pick.

APR 30· THE INSIDE ANALYST

Ford Looks Undervalued – But Its Financial Structure Tells a Different Story

Ford Motor Company appears inexpensive.The stock trades below its fair value range, But that apparent value becomes more conditional than it seems.
Ford’s revenue base has remained relatively stable, supported by its scale and market position. But operating performance has weakened. EBITDA has declined, margins have compressed, and returns on capital have deteriorated, with ROE turning negative in the most recent period. At the same time, net debt has increased, raising financial risk.Free cash flow appears strong, but the quality of that cash is less clear. A large portion reflects a reduction in finance receivables within Ford Credit, reversing prior outflows rather than indicating stronger underlying operations. This creates a clear tension: weakening performance alongside rising leverage and misleadingly strong cash flow. This situation reflects a recurring financial dynamic: Leverage Drift.

APR 27 · THE INSIDE ANALYST

How I Sanity Check a Stock Before Investing – and the Database I Built for You

Most investors don’t lack information. They lack a structured way to verify whether a stock actually holds beneath the surface – and that’s where mistakes happen. The problemRevenue grows. Margins look stable. Valuation seems reasonable. On paper, everything works.But underneath, something often doesn’t: returns weaken, cash flow becomes inconsistent, leverage creeps up.Each signal looks fine in isolation. Together, they tell a different story.The shift: Over time, I stopped looking at metrics individually. Instead, I started asking one question: Does this business actually hold together? To answer that, I built a simple sanity check. The Financial X-Ray – A structured view that connects: financial health, growth, management quality and valuation. Not as separate metrics but as a system. The goal is not more data. It’s clarity.

APR 23 · THE INSIDE ANALYST

Alphabet Is Winning – But Its Financial Signals Deserve Attention

Alphabet Inc. continues to deliver. Growth is accelerating, margins are expanding, and the business remains dominant across its core markets. But growth Is Becoming More Capital Intensive. Alphabet’s operating performance is clearly improving. Revenue growth has re-accelerated and margins have expanded to new highs. At the same time, capital intensity has increased sharply. Capex now absorbs more than 20% of revenue – a significant shift from prior years.This shows up in two key signals. First, free cash flow has remained broadly flat despite strong earnings growth. (Recall: free cash flow is measured after deducting capital expenditure from operating cash flow). Second, return on invested capital has declined toward 10%, meaning the business is generating returns closer to its cost of capital rather than well above it. This is nothing dramatic but it signals limited value creation. Third, debt rises by ~40bn to finance investments. Taken together, this suggests that growth is becoming more capital-intensive and less efficient at the margin.

APR 20 · THE INSIDE ANALYST

Barrick Looks Stronger Than Ever – Beneath the Surface Something Hasn't Actually Changed

Barrick Mining Corporation appears to be improving across the board but that progress is not coming from the business itself. Somethings makes the business look stronger than it is. Barrick’s recent performance looks strong. Revenue has grown, margins have expanded, and free cash flow has increased meaningfully. At the same time, capital intensity remains high, with significant ongoing investment required to sustain production. While returns on capital have improved recently, they remain volatile over time and sensitive to commodity price movements. This becomes evident when looking at the 2021 numbers – the first year of elevated gold prices after COVID. The Return on Invested Capital (ROIC) which measures the operating output per unit of capital spikes in 2021 and declines in the following years. The same behavior is observable across margins and cash flows – even though gold prices remained elevated. This creates a subtle tension: the business appears more profitable, but its underlying economics have not structurally improved. A large part of the improvement is driven by higher gold prices rather than operational efficiency. This situation reflects a recurring financial dynamic: price driven Margin Expansion Illusion

APR 16 · THE INSIDE ANALYST

Carnival – When a Strong Recovery Hides a Fragile Foundation

Carnival Corporation & plc appears to have moved past its crisis phase. But when the financial signals are read together, the recovery looks less stable than it appears. Carnival’s operating recovery is real. Revenue has surged as travel demand returned, and margins have rebounded to strong levels.Profitability has followed, with net income and ROE improving significantly.But the quality of these improvements remains uneven. Revenue growth has slowed after the initial rebound, margins fluctuate, and free cash flow remains volatile. At the same time, the balance sheet still carries high leverage and limited liquidity, constraining financial flexibility.The result is a clear tension: strong operating recovery alongside low stability and high financial risk. This situation reflects a recurring financial dynamic: Valuation Comfort Trap.

APR 13 · THE INSIDE ANALYST

SoFi Is Profitable And Growing – But Is the Growth Story Durable?

The narrative is shifting toward a scalable digital platform. But the financial signals suggest that one key piece of the story is still missing. SoFi’s growth remains strong. Total income has expanded rapidly as the company scales its lending and financial services platform. Profitability has also improved, with net income turning positive after several years of losses.But capital efficiency tells a different story. Return on equity remains low and volatile, indicating that the business is not yet generating strong returns on its capital base.At the same time, valuation has started to reflect this improvement. Price-to-earnings and price-to-book multiples have expanded despite limited evidence of durable returns.The tension is clear: earnings are improving, but the quality and stability of those returns remain uncertain. This situation reflects a recurring financial dynamic: Durability Overpricing.

APR 9 · THE INSIDE ANALYST

MercadoLibre’s Strong Cash Flow Is Less Durable Than It Appears

At first glance, the financial profile suggests a platform that is converting growth into cash with impressive efficiency but a more nuanced picture emerges about where that cash actually comes from. MercadoLibre’s growth remains exceptional. Revenue has expanded rapidly as its e-commerce marketplace and fintech ecosystem scale across Latin America. Operating profitability improved significantly in recent years, but that progress has begun to stabilize. At the same time, capital efficiency (ROIC) that shows whether the capital tied up in the company is efficiently used and returns better value that the cost of capital (usually 8-12%) has weakened and at the same time net debt has started to rise again. The most striking signal is cash generation. Free cash flow has surged far beyond operating earnings (EBITDA). This creates an unusual tension: the business generates significant cash, but a large portion is driven by working-capital dynamics rather than purely by operating profitability.Usually, companies face an increase in working capital that reduces free cash flow to give a textbook example of a recurring financial dynamic: Cash Conversion Fracture.

APR 6 · THE INSIDE ANALYST

Meta Is Spending More Capital – But Here Is the Dangerous Part: It Is Also Getting Less Return From It

For many investors, Meta Platforms still looks like one of the strongest businesses in the technology sector. When the financial signals are read together, a more nuanced picture emerges. Meta Platforms continues to deliver strong operating performance. Revenue growth has reaccelerated, supported by resilient digital advertising demand and high engagement across its platforms. Profitability remains exceptional, with margins among the highest in the sector. But another trend is developing beneath the surface: the business is becoming far more capital intensive. Capital expenditure has risen sharply as Meta invests heavily in AI infrastructure and data centers, absorbing a much larger share of revenue than in the past.At the same time, capital efficiency has declined. Both return on invested capital and return on equity have fallen, suggesting the expanding investment base is not yet generating proportional returns. Free cash flow remains substantial but has become more volatile as these investment cycles accelerate. The result is a clear tension: Meta is investing significantly more capital while the efficiency of that capital is declining. This situation reflects a recurring financial dynamic: Capex Shock.

APR 2 · THE INSIDE ANALYST

Chevron’s Rally Tracks Oil Prices, Not Improvements in the Business

A global oil major and a reliable dividend payer. But the underlying economics of the business are becoming more fragile as the commodity cycle shifts. Chevron remains one of the world’s largest integrated energy companies. But the recent financial signals tell a more cyclical story. Revenue, margins and capital efficiency surged during the energy boom following the post-pandemic recovery and the global supply shock in oil markets. Those conditions proved temporary. As oil prices normalized, revenue growth slowed and eventually turned negative. Profitability declined from peak levels, and operating margins compressed as commodity prices softened. Capital efficiency followed the same path. At the same time, the balance sheet began absorbing part of the pressure as net debt increased while shareholder distributions continued. Free cash flow remains significant, but its stability is largely tied to movements in oil prices rather than consistent operating improvement. The result is a financial profile that still looks strong on the surface but shows weakening momentum beneath it. This situation reflects a recurring financial dynamic: Stability Overconfidence.

MAR 29 · THE INSIDE ANALYST

Adyen – When a Fortress Balance Sheet Hides a Slowing Engine

Adyen still looks like a model fintech company. But the stock has struggled for years while the business continues to grow. That disconnect raises a subtle question investors often overlook.

MAR 26 · THE INSIDE ANALYST

Lockheed Martin’s Stock Rally Over Iran War Is Not Sustainable – The Business Faces a Quiet Deterioration in Its Economics

For many investors, Lockheed Martin represents stability. But a closer look at the financials suggests the engine behind those returns may be shifting. The revenue story is relatively straightforward. Demand for defense systems remains stable, and the company continues to benefit from long-term contracts and government spending priorities.That stability supports steady growth and reliable cash generation.However, the profitability of the business has gradually softened. Operating margins have trended lower in recent years, suggesting that the company is keeping less profit from each dollar of revenue than it used to. Net margins show a similar pattern.Another signal points in the same direction: capital efficiency. Returns on invested capital have also declined, which indicates that new capital deployed into the business is generating somewhat lower returns than in the past.But when viewed together, these shifts suggest that the operating engine of the company has become slightly less efficient over time and as operating margins soften, financial leverage gradually increases.That combination creates an interesting financial dynamic. Leverage Drift

MAR 19 · THE INSIDE ANALYST

Merck – Why a “Defensive” Pharma Giant Produces Unpredictable Financials

When investors look at a company like Merck & Co., the expectation is usually a defensive business with predictable financial results. But the financial statements tell a more complicated story. At first glance, Merck’s financial profile looks solid.Revenue has expanded over time and the company continues to operate with strong profitability compared with most healthcare peers. Pharmaceutical products with strong market positions allow the business to generate attractive margins.However, the direction and stability of the underlying financial signals reveal a more nuanced picture.Revenue growth has slowed significantly in recent years. After a period of strong expansion driven by blockbuster products and pandemic-related demand, growth momentum has faded and results have become more dependent on the performance of a smaller number of key drugs.Profitability, while still high, has also shown unusual volatility. EBITDA margins have fluctuated significantly across periods as product cycles, research investments, and regulatory developments affect results.Free cash flow shows even greater instability. In some years the company generates substantial cash, while in others cash flow drops sharply or turns negative. These swings are partly driven by the nature of pharmaceutical development cycles, where research investments, product launches, and regulatory milestones create uneven financial outcomes.Capital efficiency follows a similar pattern. Returns on invested capital and equity remain strong on average but fluctuate significantly from year to year.The balance sheet itself remains relatively conservative. Leverage is moderate and the company continues to maintain financial flexibility. However, rising net debt in recent periods slightly offsets that stability.Taken together, the signals reveal an important interaction:The business remains fundamentally strong, but the financial outcomes are unusually volatile for a company perceived as defensive.This situation reflects a financial dynamic that does not fit into a framework and that is called Pharma Earnings Volatility – a financial pattern closest related to cash conversion fracture – when margins don’t translate into free cash flow (

MAR 16 · THE INSIDE ANALYST

ServiceNow – When Hypergrowth Becomes Healthy Growth

ServiceNow’s growth is slowing. That’s the headline investors focus on. But beneath the surface something unusual is happening. The business is getting stronger as the market becomes more cautious. ServiceNow remains one of the strongest enterprise software businesses in the market.Revenue growth is still exceptional by large-cap standards, remaining above 20 percent annually. Sustaining that level of expansion at scale reflects strong demand for workflow automation and enterprise digital transformation.At the same time, profitability has improved significantly. EBITDA margins have expanded as the platform scales and operating leverage materializes. The company increasingly benefits from the typical software dynamic: once core infrastructure and development costs are absorbed, incremental revenue becomes more profitable.Cash generation follows the same direction. Free cash flow has increased meaningfully, reinforcing the financial resilience of the business model.The balance sheet has strengthened as well. Net debt has declined, leaving the company with substantial financial flexibility.In other words, the economic quality of the business is improving.But the nature of growth is gradually changing.Revenue expansion is normalising from earlier hyper-growth levels as the company becomes larger. That shift is natural for a platform reaching greater scale, yet it often changes how investors interpret the story.Markets tend to focus heavily on the direction of growth, sometimes overlooking simultaneous improvements in profitability, capital efficiency, and cash generation.This creates a subtle tension: the fundamentals continue to strengthen even as the headline growth rate moderates.This situation reflects a recurring financial dynamic:The Growth Normalization Paradox.

MAR 12 · THE INSIDE ANALYST

The Inside Analyst

Want to receive top stories by email? Subscribe on Substack

Find the stocks the market is misreading

How The Inside Analyst works

Why investors use the Financial X-Ray

The Financial X-Ray

What to expect